Research | Open Access | Volume 9 (1): Article  08 | Published: 09 Jan 2026

Epidemiological profile of extrapulmonary tuberculosis in the Centre-Est region of Burkina Faso, 2021–2023

Views: 481

   Menu, Tables and Figures

Navigate this article

Table 1: Distribution of extrapulmonary tuberculosis cases by sociodemographic characteristics, Centre-Est region, Burkina Faso (2021–2023)

Table 2: Distribution of extrapulmonary tuberculosis cases by anatomical site, Centre-Est region, Burkina Faso (2021–2023)

Table 3: Distribution of extrapulmonary tuberculosis cases by anatomical site and treatment outcome, Centre-Est region, Burkina Faso, 2021–2023 (n = 191)

Keywords

  • Burkina Faso
  • Epidemiology
  • Health services accessibility
  • Treatment outcome
  • Extrapulmonary tuberculosis

Saïdou‑Mady Bagaya1,&, Issaka Bebane2, Morou Nikiema1, Kouka Joseph Ouedraogo1, Djibril Boro1, Kobena Naon1, Dahourou Sou1, Issa Guire1, Franck Palamanga Obulbiga3, Denis Yelbeogo4

1Regional Health Directorate, Centre‑Est Region, Ministry of Health, Burkina Faso, 2Regional Hospital Center of Tenkodogo, Centre‑Est Region, Ministry of Health, Burkina Faso, 3Health Emergency Operations Center, Ministry of Health, Burkina Faso, 4Field Epidemiology Training Program (FETP) Coordination, Frontline and Intermediate, Burkina Faso

&Corresponding author: Saïdou‑Mady Bagaya, Regional Health Directorate, Centre‑Est Region, Ministry of Health, Burkina Faso, Email: bagayasm@yahoo.fr, ORCID: https://orcid.org/0009-0003-2507-5244

Received: 26 Sep 2025, Accepted: 08 Jan 2026, Published: 09 Jan 2026

Domain: Infectious Disease Epidemiology

Keywords: Burkina Faso, epidemiology, health services accessibility, treatment outcome, extrapulmonary tuberculosis

©Saïdou‑Mady Bagaya et al. Journal of Interventional Epidemiology and Public Health (ISSN: 2664-2824). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article: Saïdou‑Mady Bagaya et al., Epidemiological profile of extrapulmonary tuberculosis in the Centre-Est region of Burkina Faso, 2021–2023. Journal of Interventional Epidemiology and Public Health. 2026;9(1):08. https://doi.org/10.37432/jieph-d-25-00207

Abstract

Introduction: Extrapulmonary tuberculosis (EPTB) accounts for a variable proportion of tuberculosis cases in Africa and remains difficult to diagnose due to its often atypical clinical presentation. In Burkina Faso, epidemiological information on EPTB is limited, particularly in the Centre‑Est region, which faces a fragile security context disrupting access to care. We described the epidemiological profile of EPTB cases reported between 2021 and 2023.
Methods: We conducted a descriptive cross‑sectional study covering the period from January 1, 2021, to December 31, 2023. All bacteriologically confirmed or clinically/radiologically diagnosed cases of EPTB were included. Sociodemographic, clinical, diagnostic, and treatment outcome data were collected using a KoboToolbox electronic form and analyzed with STATA 15.1.
Results: Among 1,581 tuberculosis cases notified during the study period, 191(12%) were extrapulmonary forms. The median age was 35 years (IQR: 19–54), and males accounted for 68.6% (131/191) of cases, with a male-to-female sex ratio of 2.18. The most affected occupational groups were unemployed individuals, 36.7% (70/191) and farmers, 27.2% (52/191). The most frequent anatomical sites were osteoarticular 53.9% (103/191), pleural 26.7% (51/191), and abdominal 7.3% (14/191). Bacteriological confirmation was achieved in 5.8% (11/191) of cases. Treatment outcomes showed 82.2% (157/191) success, 6.8% (13/191) default, and 11.0% (21/191) mortality.
Conclusion: EPTB remains likely underdiagnosed in the Centre‑Est region of Burkina Faso. The predominance of osteoarticular forms, together with a default rate above the national target and a high mortality rate in a context of insecurity, highlights the need to strengthen diagnostic capacities and adapt community follow-up strategies to improve patient management.

Introduction

Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis complex and is primarily transmitted through airborne droplets. Although it predominantly affects the lungs, it can also involve other organs, resulting in extrapulmonary manifestations [1]. Extrapulmonary tuberculosis (EPTB) is usually paucibacillary, which complicates bacteriological confirmation. Its atypical and nonspecific clinical presentation often hinders timely diagnosis and management. Among people living with HIV, EPTB may represent more than half of all tuberculosis cases [2].

In 2023, the World Health Organization (WHO) estimated that 10.8 million people developed tuberculosis worldwide, leading to approximately 1.25 million deaths [1]. Extrapulmonary forms are thought to represent 15–20% of notified cases [3]. In Africa, a 2024 meta-analysis reported an overall prevalence of 26%, with regional variation from 16% in West Africa to 32% in East Africa [4].

In Burkina Faso, the overall tuberculosis incidence was estimated at 44 cases per 100,000 population in 2023 [5]. However, national reports focus mainly on pulmonary disease, providing little information on EPTB [5,6]. In the Centre-Est region, published data remain scarce, although diagnosis and treatment centres (DTCs) regularly encounter such cases [7].

In some areas of the region, insecurity has led to the partial or complete closure of health facilities and significant population displacement [8,9]. This study described the epidemiological, clinical, and treatment characteristics of EPTB cases reported between 2021 and 2023 in the DTCs of the Centre-Est region, in order to strengthen strategies for patient management and prevention.

Methods

Study setting
The Centre-Est region of Burkina Faso borders Togo and Ghana, covers an area of 15,288 km², and had an estimated population of 1.75 million in 2023 [10]. It comprises three provinces and 30 communes. The economy is largely based on agriculture, with artisanal gold mining widely practised [11]. Health services include a regional hospital center, several district-level medical centers with surgical units, and a network of primary health facilities (Centres de Santé et de Promotion Sociale, CSPS). Tuberculosis care is organized around nine diagnosis and treatment centers (DTCs) distributed across the seven health districts. These facilities ensure case detection, diagnostic confirmation, and treatment follow-up, while CSPS support specimen collection and community-based patient monitoring [12].

Study design and period
We conducted a descriptive cross-sectional study covering the period from January 1, 2021, to December 31, 2023.

Study population
The study included all patients recorded as new or relapse tuberculosis cases in the nine diagnosis and treatment centres (DTCs) of the Centre-Est region during the study period. Eligible participants were patients diagnosed with extrapulmonary tuberculosis, either bacteriologically confirmed (by microscopy, Xpert MTB/RIF, or culture) or clinically and/or radiologically diagnosed. Extrapulmonary tuberculosis cases with missing or insufficient data that did not allow confirmation of the anatomical site, diagnostic method, or treatment outcome were excluded.

Sampling strategy
An exhaustive sampling approach was applied, including all cases that met the inclusion criteria.

Data sources and collection
Data were extracted from standardized tuberculosis registers maintained in DTCs and entered into an electronic form designed on the KoboToolbox platform.

Study variables
Variables analyzed included sociodemographic characteristics (age, sex, occupation, and residence), clinical and diagnostic features (site of extrapulmonary involvement, diagnostic method), and the proportion of EPTB among all notified tuberculosis cases.

Operational definitions
Treatment outcomes were defined according to the Burkina Faso National Tuberculosis Control Program guidelines.
Cured referred to patients with bacteriologically confirmed tuberculosis at treatment initiation who had negative bacteriological results (smear or culture) during the last month of treatment and on at least one previous occasion. Treatment completed referred to patients who completed their full course of anti-tuberculosis treatment without evidence of treatment failure, including patients with clinically diagnosed extrapulmonary tuberculosis for whom bacteriological confirmation or end-of-treatment results were not available. Treatment success corresponded to the sum of patients classified as cured and those who completed treatment. Default (lost to follow-up) referred to patients who interrupted anti-tuberculosis treatment for at least two consecutive months after treatment initiation. Death was defined as any death occurring during the course of anti-tuberculosis treatment or before treatment initiation, regardless of the cause.

Data analysis
Data were analyzed using STATA version 15.1. Results are presented as frequencies, proportions, and ratios, with distributions by age, sex, site of involvement, and treatment outcomes (overall and site-specific).

Ethical considerations
Authorization to use tuberculosis surveillance data was obtained from the Regional Health Directorate of the Centre-Est region and the National Tuberculosis Control Program. This study used routine programmatic data and did not involve direct contact with patients. All data were anonymized prior to analysis by removing personal identifiers. Access to the database was restricted to the study investigators. Data were stored in password-protected electronic files to ensure confidentiality and data security. Data consistency and completeness checks were performed during data entry and analysis to ensure data integrity.

Results

From 2021 to 2023, a total of 1,581 tuberculosis cases (new and relapse) were reported in the Centre-Est region. Of these, 12% (191/1,581) were extrapulmonary. The 191 patients had a median age of 35 years (IQR: 19–54). Adults aged 45 years and older accounted for 67 cases (35.1%). Males accounted for 131 cases (68.6%), with a male-to-female sex ratio of 2.18. Regarding occupation, 70 patients (36.7%) were unemployed and 52 (27.2%) were farmers. The districts of Tenkodogo and Garango reported 66 (34.6%) and 37 (19.4%) cases, respectively, whereas Ouargaye and Bittou reported 3 (1.6%) and 5 (2.6%) cases (Table 1).

Most cases (94.2%; 180/191) were clinically diagnosed, while 11 cases (5.8%) were bacteriologically confirmed, using Xpert MTB/RIF or culture. HIV status was documented for 180 patients, among whom 11 (6.1%) tested positive. Osteoarticular tuberculosis accounted for 103 cases (53.9%), including 99 cases with vertebral involvement (Pott’s disease). Pleural tuberculosis accounted for 51 cases (26.7%) (Table 2).

Treatment outcomes differed according to anatomical site. Among abdominal forms, 4 of 14 patients died (28.6%). Among pleural forms, treatment success was recorded in 47 of 51 patients (92.2%). For osteoarticular forms, default was recorded in 10 of 103 patients (9.7%) and death in 9 patients (8.7%). Among lymph-node forms, 2 of 12 patients died (16.7%), while among other extrapulmonary sites, 2 of 11 patients died (18.2%) (Table 3).

Discussion

The proportion of extrapulmonary tuberculosis observed in our setting was lower than that reported in hospital-based studies from Burkina Faso and other African countries [13–16]. Rather than indicating a truly lower burden of disease, this finding likely reflects underdiagnosis, related to the paucibacillary nature of extrapulmonary forms, their often non-specific clinical presentation, and limited access to confirmatory diagnostic tests. In practice, the diagnosis of extrapulmonary tuberculosis frequently relies on invasive procedures such as pleural puncture or biopsy, followed by specialized investigations including histopathology, culture, or Xpert MTB/RIF [17,18]. These diagnostic approaches require adequate laboratory infrastructure and trained personnel, which are rarely available in peripheral health facilities in our context. Security constraints further restrict access to care and exacerbate these diagnostic challenges.

The very low level of bacteriological confirmation observed in this study highlights important operational constraints within the health system of the Centre-Est region. Limited availability of diagnostic tools such as Xpert MTB/RIF, culture, or histopathology at peripheral health facilities represents a major constraint. Disruptions in sample transport and referral pathways related to insecurity likely explain the predominance of clinically diagnosed cases.

The geographical distribution of extrapulmonary tuberculosis cases showed a clear predominance in health districts hosting or located near referral facilities. Higher case detection in Tenkodogo may be explained by the presence of the regional hospital, which is equipped with specialist staff and diagnostic tools. Similarly, proximity to this facility may facilitate patient referral and access to confirmatory investigations in neighboring districts such as Garango. In contrast, districts such as Ouargaye and Bittou, which are more affected by insecurity and have limited access to specialized diagnostic services, reported fewer cases. This pattern likely reflects barriers to healthcare access rather than a lower occurrence of disease.

These geographic disparities call for strengthening peripheral diagnostic capacity, including decentralization of imaging and access to Xpert MTB/RIF testing, as well as improvement of referral and sample transport systems. In addition, implementation of adapted community-based follow-up strategies in districts most affected by insecurity is needed to reduce inequalities in access to diagnosis and care for extrapulmonary tuberculosis.

The marked male predominance observed in our study (68.6% of cases) is consistent with findings reported in other settings in Africa and Asia [19–21]. This pattern may be explained by occupational exposure in artisanal gold mining and agriculture. It may also be related to risk behaviours more common among men, such as tobacco smoking and heavy alcohol consumption, which are known to increase susceptibility to tuberculosis, including extrapulmonary forms [23]. In contrast, lower case detection among women may reflect barriers to healthcare access rather than reduced exposure. Insecurity-related constraints on women’s mobility, together with persistent socioeconomic inequalities, may limit their timely access to health services, particularly for extrapulmonary forms requiring specialized diagnostic investigations [8,11]. This situation suggests a probable under-detection of extrapulmonary tuberculosis among women and underscores the need to strengthen community-based screening and improve access to care for women in the most affected districts.

The age distribution observed in this study is consistent with known epidemiological patterns of tuberculosis. The predominance of adults aged 45 years and older may be explained by cumulative lifetime exposure to Mycobacterium tuberculosis, a higher prevalence of comorbidities, and age-related immune decline, which may predispose to extrapulmonary disease. At the same time, the substantial proportion of young adults aged 15–24 years affected (20.4%) may reflect increased exposure related to mobility and occupational activities. In the Centre-Est region, many individuals in this age group are engaged in artisanal gold mining, an environment often characterized by overcrowding, poor ventilation, silica dust exposure, and precarious living conditions, all of which increase the risk of tuberculosis infection.

Socioeconomic vulnerability also appears to play an important role in the occurrence of extrapulmonary tuberculosis. The predominance of unemployed individuals (51.3%), farmers (26.7%), and gold miners (16.7%) highlights the contribution of poverty, overcrowding, and high-risk work environments. These findings are consistent with reports from other African settings [22,23] and emphasize the importance of preventive strategies targeting vulnerable populations and high-risk occupational settings.

From a clinical perspective, osteoarticular tuberculosis was the predominant extrapulmonary form in our setting (53.9% of cases), contrasting with findings from several African studies in which pleural and lymph node involvement are more frequent [14,24]. This pattern may reflect contextual diagnostic factors rather than true epidemiological differences. The availability of radiography and Xpert MTB/RIF in district hospitals facilitates the detection of spinal and osteoarticular forms, which often present at a more advanced clinical stage and with more pronounced symptoms. In contrast, pleural and lymph node forms, which are frequently less symptomatic or require invasive diagnostic procedures, may be underdiagnosed in peripheral health facilities.

Regarding treatment outcomes, the overall treatment success rate observed in this study (82.2%) remained below the target set by the Burkina Faso National Tuberculosis Control Program (≥85%). Although comparable to results reported in some Central African settings, it was lower than those observed in Ethiopia [24,25]. Overall mortality was 11.0%, with particularly high rates among patients with abdominal (28.6%), lymph node (16.7%), and other severe extrapulmonary forms.

Several factors may explain these findings. Insecurity affecting parts of the region likely limits timely access to healthcare, delays diagnosis, and disrupts continuity of treatment. In addition, the predominance of clinically diagnosed cases without bacteriological confirmation may reflect management at a more advanced clinical stage of disease. Finally, the high proportion of severe forms, particularly abdominal and osteoarticular tuberculosis, as well as the possible presence of comorbidities such as HIV infection, may have contributed to the elevated mortality observed. These findings underscore the need to strengthen early case detection, improve access to confirmatory diagnostic tools, and adapt patient follow-up and management strategies for extrapulmonary tuberculosis, particularly in settings affected by insecurity.

Limitations of the study
The main limitation of this study was the low rate of bacteriological confirmation for extrapulmonary tuberculosis. Most diagnoses were established on clinical grounds, with only about 6% confirmed by laboratory tests. This may have led to misclassification of disease sites and potential over- or under-diagnosis depending on the availability of Xpert MTB/RIF, culture, or histopathology. Despite this limitation, our findings provide valuable insight into the burden of EPTB in the Centre-Est region and inform strategies to strengthen case detection and management.

Conclusion

Our findings indicate that extrapulmonary tuberculosis is likely underdiagnosed in the Centre-Est region of Burkina Faso, accounting for only 12% of reported TB cases. Osteoarticular disease, particularly Pott’s disease, predominated. The overall treatment success rate (82.2%) fell short of the WHO target, with substantial rates of treatment default and mortality, especially in districts affected by insecurity.

These results underscore the need to strengthen diagnostic capacity in peripheral facilities, expand access to specialized investigations, and reinforce community-based follow-up strategies. Targeted efforts are required for economically vulnerable populations and health districts in fragile security contexts to reduce loss to follow-up and improve treatment outcomes for EPTB.

What is already known about the topic

  • Extrapulmonary tuberculosis (EPTB) accounts for 15–20% of global tuberculosis cases.
  • In Africa, it is more frequent, with an estimated prevalence of around 26%.
  • Diagnosis is often difficult due to atypical clinical signs and limited access to specialized tests.
  • In Burkina Faso, available data are scarce and mainly concern pulmonary forms

What this  study adds

  • Provides the first detailed description of the epidemiological profile of EPTB in the Centre-Est region of Burkina Faso.
  • Reveals an unusual predominance of osteoarticular forms, in contrast to patterns observed in other African settings.
  • Identifies a treatment success rate below the WHO target, with high proportions of death and treatment default.
  • Highlights the impact of insecurity and socioeconomic vulnerability on continuity of care and treatment outcomes.

Competing Interest

The authors of this work declare no competing interests.

Funding

The authors did not receive any specific funding for this work.

Acknowledgements

We are grateful to the Centre-Est Regional Health Directorate and the staff of tuberculosis diagnosis and treatment centers for their collaboration. We also thank the National Tuberculosis Control Program for its technical support, and the community health workers who assisted with data collection and entry.

Authors´ contributions

Bagaya Saïdou-Mady: study conception, supervision, data analysis, and manuscript drafting.
Issiaka Bebane, Issa Guire and Kouka Joseph Ouedraogo Djibril Boro: data collection, validation, and organization.
Morou Nikiema, Kobena Naon, Dahourou Sou and Djibril Boro: contribution to data analysis and interpretation of results.
Franck Palamanga Obulbiga and Denis Yelbeogo : critical revision of the manuscript and substantial improvements.

Tables 

Table 1: Distribution of extrapulmonary tuberculosis cases by sociodemographic characteristics, Centre-Est region, Burkina Faso (2021–2023)
Characteristics Frequency (n=191) Percentage (%)
Age (years)
<15 27 14.1
15–24 39 20.4
25–34 28 14.7
35–44 30 15.7
≥45 67 35.1
Sex
Male 131 68.6
Female 60 31.4
Occupation
Unemployed 70 36.7
Farmer 52 27.2
Gold miner 32 16.8
Trader 19 10.0
Student 12 6.3
Salaried worker 6 3.1
Health district
Tenkodogo 66 34.6
Garango 37 19.4
Koupéla 36 18.9
Pouytenga 26 13.6
Zabré 18 9.4
Bittou 5 2.6
Ouargaye 3 1.6
Table 2: Distribution of extrapulmonary tuberculosis cases by anatomical site, Centre-Est region, Burkina Faso (2021–2023)
Anatomical site Cases (n=191) Percentage (%)
Osteoarticular 103 53.9
Pleural 51 26.7
Abdominal (peritoneal, intestinal) 14 7.3
Lymph node 12 6.3
Other (meningeal, pericardial, mammary) 11 5.8
Table 3: Distribution of extrapulmonary tuberculosis cases by anatomical site and treatment outcome, Centre-Est region, Burkina Faso, 2021–2023 (n = 191)
Anatomical site Cases n (%) Treatment success n (%) Default n (%) Death n (%)
Lymph node 12 (6.3) 10 (83.3) 0 2 (16.7)
Pleural 51 (26.7) 47 (92.2) 1 (2.0) 3 (5.9)
Osteoarticular 103 (53.9) 84 (81.6) 10 (9.7) 9 (8.7)
Abdominal1 14 (7.3) 9 (64.3) 1 (7.1) 4 (28.6)
Other2 11 (5.8) 8 (72.7) 1 (9.1) 2 (18.2)
Total 191 (100) 157 (82.2) 13 (6.8) 21 (11.0)
1Abdominal: peritoneal, intestinal. 2Other: meningeal, pericardial, mammary.
 

References

  1. World Health Organization. Global tuberculosis report 2024 [Internet]. Geneva: World Health Organization; 2024 Oct 29 [cited 2026 Jan 9]. 50 p. Available from: https://iris.who.int/server/api/core/bitstreams/7292c91e-ffb0-4cef-ac39-0200f06961ea/content
  2. Mohammed H, Assefa N, Mengistie B. Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in sub-Saharan Africa: a systematic review and meta-analysis. HIV AIDS (Auckl) [Internet]. 2018 Nov 5 [cited 2026 Jan 9];10:225–37. doi:10.2147/HIV.S176587
  3. Baykan AH, Sayiner HS, Aydin E, Koc M, Inan I, Erturk SM. Extrapulmonary tuberculosis: an old but resurgent problem. Insights Imaging [Internet]. 2022 Mar 7 [cited 2026 Jan 9];13(1):39. Available from: https://insightsimaging.springeropen.com/articles/10.1186/s13244-022-01172-0 doi:10.1186/s13244-022-01172-0
  4. Hailu S, Hurst C, Cyphers G, Thottunkal S, Harley D, Viney K, Irwin A, Dean J, Nourse C. Prevalence of extra-pulmonary tuberculosis in Africa: A systematic review and meta-analysis. Trop Med Int Health [Internet]. 2024 Jan 23 [cited 2026 Jan 9];29(4):257–65. Available from: https://onlinelibrary.wiley.com/doi/10.1111/tmi.13970 doi:10.1111/tmi.13970
  5. World Bank. Incidence of tuberculosis (per 100,000 people) – Burkina Faso [Internet]. Washington (DC): World Bank; 2024 [cited 2026 Jan 9]. [about 1 screen]. Available from: https://data.worldbank.org/indicator/SH.TBS.INCD?locations=BF
  6. Ministère de la Santé et de l’Hygiène Publique (Burkina Faso). Annuaire statistique 2024 [Statistical Yearbook 2024] [Internet]. Ouagadougou (Burkina Faso): Ministère de la Santé et de l’Hygiène Publique; 2025 Apr [cited 2026 Jan 9]. 499 p. Available from: https://www.sante.gov.bf/fileadmin/annuaire_2024_ms__signe___18062025.pdf
  7. Ministère de la Santé (Burkina Faso). Plan stratégique de lutte antituberculeuse 2008-2012 [Strategic Plan for Tuberculosis Control 2008-2012] [Internet]. Ouagadougou (Burkina Faso): Ministère de la Santé; 2007 Dec [cited 2026 Jan 9]. 69 p. Available from: https://extranet.who.int/countryplanningcycles/sites/default/files/country_docs/Burkina%20Faso/burkina_faso_plan_strategique_de_lutte_contre_la_tuberculose_2008-2012.pdf
  8. United Nations High Commissioner for Refugees. Rapport mensuel de monitoring de la protection – Région du Centre-Est, avril 2024 [Monthly protection monitoring report – Centre-East region, April 2024] [Internet]. Geneva (Switzerland): United Nations High Commissioner for Refugees; 2024 Jun 3 [cited 2026 Jan 9]. 13 p. Available from: https://data.unhcr.org/en/documents/details/109081
  9. UNICEF. Burkina Faso – Humanitarian Situation Report No. 5 [Internet]. New York (NY): UNICEF; 2025 May [cited 2026 Jan 9]. 11 p. Available from: https://www.unicef.org/media/171651/file/Burkina-Faso-Humanitarian-SitRep-May-2025.pdf
  10. Institut National de la Statistique et de la Démographie (Burkina Faso). Cinquième Recensement Général de la Population et de l’Habitat du Burkina Faso [Fifth General Population and Housing Census of Burkina Faso] [Internet]. Ouagadougou (Burkina Faso): Institut National de la Statistique et de la Démographie; 2022 [cited 2026 Jan 9]. 133 p. Available from: http://cns.bf/IMG/pdf/rapport_resultats_definitifs_rgph_2019.pdf
  11. Institut national de la statistique et de la démographie (Burkina Faso). Profil de pauvreté Centre-Est [Poverty profile of the Central East region] [Internet]. 2024 Oct [cited 2026 Jan 9]. 31 p. Available from: https://www.insd.bf/sites/default/files/2024-02/PROFIL%20DE%20PAUVRETE%20CENTRE%20EST%20VF.pdf
  12. Ministère de la Santé (Burkina Faso). Guide technique pour la prise en charge de la tuberculose, 10e édition [Technical guide for the management of tuberculosis, 10th edition] [Internet]. Ouagadougou (Burkina Faso): Ministère de la Santé; 2025 Apr [cited 2026 Jan 9]. 114 p. Available from: [direct link not provided in original – document reference: PNT_Guide_technique_de_lutte_contre_la_TB_version finale 2025.pdf]
  13. Maïga S, Ouédraogo KO, Nacanabo RN, Sawadogo A, Ouédraogo AR, Boncoungou K, Namono S, Ouédraogo GA, Kuiré M, Ouédraogo G, Badoum G, Ouédraogo M. Epidemio-clinical profile and therapeutic outcome of tuberculosis in the city of Ouahigouya – Burkina Faso. J Func Vent Pulm [Internet]. 2021 [cited 2026 Jan 9];36(12):1-75. Available from: https://www.jfvpulm.com/librarys/uploads/090827-ARTICLE-3_JFVP36.pdf
  14. Ohene SA, Bakker MI, Ojo J, Toonstra A, Awudi D, Klatser P. Extra-pulmonary tuberculosis: A retrospective study of patients in Accra, Ghana. PLoS ONE [Internet]. 2019 Jan 9 [cited 2026 Jan 9];14(1):e0209650. Available from: https://doi.org/10.1371/journal.pone.0209650 doi:10.1371/journal.pone.0209650
  15. Mbuh TP, Ane-Anyangwe I, Adeline W, Thumamo Pokam BD, Meriki HD, Mbacham WF. Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon. BMC Pulm Med [Internet]. 2019 Jan 17 [cited 2026 Jan 9];19(1):17. Available from: https://doi.org/10.1186/s12890-018-0770-x doi:10.1186/s12890-018-0770-x
  16. Arega B, Mersha A, Minda A, Getachew Y, Sitotaw A, Gebeyehu T, Agunie A. Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia. Quinn F, editor. PLoS ONE [Internet]. 2020 Dec 15 [cited 2026 Jan 9];15(12):e0243945. Available from: https://doi.org/10.1371/journal.pone.0243945 doi:10.1371/journal.pone.0243945
  17. Lusiba JK, Nakiyingi L, Kirenga BJ, Kiragga A, Lukande R, Nsereko M, Ssengooba W, Katamba A, Worodria W, Joloba ML, Mayanja-Kizza H. Evaluation of Cepheid’s Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting. PLoS ONE [Internet]. 2014 Jul 22 [cited 2026 Jan 9];9(7):e102702. Available from: https://doi.org/10.1371/journal.pone.0102702 doi:10.1371/journal.pone.0102702
  18. Chakrabarti B, Davies PDO. Pleural tuberculosis. Monaldi Arch Chest Dis [Internet]. 2016 Feb 15 [cited 2026 Jan 9];65(1). Available from: https://doi.org/10.4081/monaldi.2006.582 doi:10.4081/monaldi.2006.582
  19. Addai YN, Acquah SEK, Ganu HM, Vicar EK, Zeyeh D, Karim AA, Williams W, Attipoe IM, Quaye L. Extrapulmonary tuberculosis in Africa: Molecular analysis of clinical specimens of suspected cases in Northern Ghana. Public Health Challenges [Internet]. 2024 Feb 14 [cited 2026 Jan 9];3(1):e160. Available from: https://doi.org/10.1002/puh2.160 doi:10.1002/puh2.160
  20. Adepoju VA, Jamil S, Ifeanyi-Ukaegbu IG, Sokoya OD, Chowdhury AA, Biswas MS. Epidemiology and clinical characteristics of musculoskeletal extrapulmonary tuberculosis in Lagos, Nigeria. Health Sci Rep [Internet]. 2025 Jul [cited 2026 Jan 9];8(7):e71108. Available from: https://doi.org/10.1002/hsr2.71108 doi:10.1002/hsr2.71108
  21. Rupani MP, Soundararajan S. Survival analysis shows tuberculosis patients with silicosis experience earlier mortality and need employer-led care models in occupational settings in India. Sci Rep [Internet]. 2024 Nov 21 [cited 2026 Jan 9];14(1):28891. Available from: https://doi.org/10.1038/s41598-024-80367-5 doi:10.1038/s41598-024-80367-5
  22. Dellal M, Batoui S, Chetoui A, Kanouf M, Fatihi T, Habbari K. Extrapulmonary tuberculosis in Morocco: A systematic review of observational studies. Rev Soc Bras Med Trop [Internet]. 2025 Mar 17 [cited 2026 Jan 9];58:e00402-2024. Available from: https://doi.org/10.1590/0037-8682-0066-2024 doi:10.1590/0037-8682-0066-2024
  23. Ehrlich R, Akugizibwe P, Siegfried N, Rees D. The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis. BMC Public Health [Internet]. 2021 May 20 [cited 2026 Jan 9];21(1):953. Available from: https://doi.org/10.1186/s12889-021-10711-1 doi:10.1186/s12889-021-10711-1
  24. Diriba G, Alemu A, Eshetu K, Yenew B, Gamtesa DF, Tola HH. Bacteriologically confirmed extrapulmonary tuberculosis and the associated risk factors among extrapulmonary tuberculosis suspected patients in Ethiopia: A systematic review and meta-analysis. PLoS ONE [Internet]. 2022 Nov 23 [cited 2026 Jan 9];17(11):e0276701. Available from: https://doi.org/10.1371/journal.pone.0276701 doi:10.1371/journal.pone.0276701
  25. Pefura Yone EW, Kuaban C, Kengne AP. HIV testing, HIV status and outcomes of treatment for tuberculosis in a major diagnosis and treatment centre in Yaounde, Cameroon: a retrospective cohort study. BMC Infect Dis [Internet]. 2012 Dec [cited 2026 Jan 9];12(1):190. Available from: https://doi.org/10.1186/1471-2334-12-190 doi:10.1186/1471-2334-12-190
Views: 481